CD8A and cancer: Worse outcomes, in which cancer cells grow beyond their initial plated count, occur at low CAR T-cell doses, at 100:0 and 0:100 CD4+:CD8+ ratios, with the weakest CAR affinity, or with lower cancer cell antigen expression.